NCT07345936 Endoscopic Treatment of Post Surgical Biliary Tract Injury
| NCT ID | NCT07345936 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Biliary Tract Injuries |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2025-10-17 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2025-10-17 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to determine the technical and clinical success rate of endoscopic treatment in a population presenting only with iatrogenic injuries of the bile ducts, excluding the cystic duct.
Eligibility Criteria
Inclusion Criteria: * Adult (≥18 years old) * Subject who has had a wound of the common bile duct or intrahepatic bile ducts following hepatobiliary surgery (laparotomy or laparoscopic cholecystectomy or major or minor hepatectomy) * Subject treated in one of the associated centers between January 1, 2021, and December 31, 2024 Exclusion Criteria: * Biliary wound occurring on a long cystic duct or gallbladder stump during partial cholecystectomy. * Biliary leakage complicating liver transplantation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07345936 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Biliary Tract Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07345936 currently recruiting?
Yes, NCT07345936 is actively recruiting participants. Contact the research team at pierre-emmanuel.mayer@chru-strasbourg.fr for enrollment information.
Where is the NCT07345936 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07345936 clinical trial?
NCT07345936 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 220 participants.